Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Y Park

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The New Phytologist|August 12, 2025
Herbariograph: a deep-learning tool to classify specimen imagesFabio Andrés Ávila, John Y Park, Leanna Feder, et al.
Pharmacology, Biochemistry, and Behavior|June 8, 2007
The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacyKaren L Eskow, Vikas Gupta, Salmahn Alam, et al.
The European Journal of Neuroscience|July 5, 2006
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulationChristopher Bishop, Jennifer L Taylor, Donald M Kuhn, et al.
Synapse (New York, N.Y.)|March 25, 2009
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsKaren L Eskow, Kristin B Dupre, Christopher J Barnum, et al.
Psychopharmacology|June 12, 2008
Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian ratKristin B Dupre, Karen L Eskow, Aimee Steiniger, et al.
Frontiers in Plant Science|February 18, 2022
The Herbarium 2021 Half-Earth Challenge Dataset and Machine Learning CompetitionRiccardo de Lutio, John Y Park, Kimberly A Watson, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 29, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical TrialDavid S Boyer, Victor H Gonzalez, Derek Y Kunimoto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The New Phytologist|August 12, 2025
Herbariograph: a deep-learning tool to classify specimen imagesFabio Andrés Ávila, John Y Park, Leanna Feder, et al.
Pharmacology, Biochemistry, and Behavior|June 8, 2007
The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacyKaren L Eskow, Vikas Gupta, Salmahn Alam, et al.
The European Journal of Neuroscience|July 5, 2006
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulationChristopher Bishop, Jennifer L Taylor, Donald M Kuhn, et al.
Synapse (New York, N.Y.)|March 25, 2009
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian ratsKaren L Eskow, Kristin B Dupre, Christopher J Barnum, et al.
Psychopharmacology|June 12, 2008
Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian ratKristin B Dupre, Karen L Eskow, Aimee Steiniger, et al.
Frontiers in Plant Science|February 18, 2022
The Herbarium 2021 Half-Earth Challenge Dataset and Machine Learning CompetitionRiccardo de Lutio, John Y Park, Kimberly A Watson, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 29, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical TrialDavid S Boyer, Victor H Gonzalez, Derek Y Kunimoto, et al.
Pageof 1